Cargando…
Treatment of Basal Cell Carcinoma with Electrochemotherapy: Insights from the InspECT Registry (2008–2019)
This prospective registry-based study aims to describe electrochemotherapy (ECT) modalities in basal cell carcinoma (BCC) patients and evaluate its efficacy, safety, and predictive factors. The International Network for Sharing Practices of Electrochemotherapy (InspECT) multicentre database was quer...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406883/ https://www.ncbi.nlm.nih.gov/pubmed/36005161 http://dx.doi.org/10.3390/curroncol29080423 |
_version_ | 1784774230104080384 |
---|---|
author | Bertino, Giulia Muir, Tobian Odili, Joy Groselj, Ales Marconato, Roberto Curatolo, Pietro Kis, Erika Lonkvist, Camilla Kjaer Clover, James Quaglino, Pietro Kunte, Christian Spina, Romina Seccia, Veronica de Terlizzi, Francesca Campana, Luca Giovanni |
author_facet | Bertino, Giulia Muir, Tobian Odili, Joy Groselj, Ales Marconato, Roberto Curatolo, Pietro Kis, Erika Lonkvist, Camilla Kjaer Clover, James Quaglino, Pietro Kunte, Christian Spina, Romina Seccia, Veronica de Terlizzi, Francesca Campana, Luca Giovanni |
author_sort | Bertino, Giulia |
collection | PubMed |
description | This prospective registry-based study aims to describe electrochemotherapy (ECT) modalities in basal cell carcinoma (BCC) patients and evaluate its efficacy, safety, and predictive factors. The International Network for Sharing Practices of Electrochemotherapy (InspECT) multicentre database was queried for BCC cases treated with bleomycin-ECT between 2008 and 2019 (n = 330 patients from seven countries, with 623 BCCs [median number: 1/patient; range: 1–7; size: 13 mm, range: 5–350; 85% were primary, and 80% located in the head and neck]). The procedure was carried out under local anaesthesia in 68% of cases, with the adjunct of mild sedation in the remaining 32%. Of 300 evaluable patients, 242 (81%) achieved a complete response (CR) after a single ECT course. Treatment naïvety (odds ratio [OR] 0.35, 95% confidence interval [C.I.] 0.19–0.67, p = 0.001) and coverage of deep tumour margin with electric pulses (O.R. 5.55, 95% C.I. 1.37–21.69, p = 0.016) predicted CR, whereas previous radiation was inversely correlated (O.R. 0.25, p = 0.0051). Toxicity included skin ulceration (overall, 16%; G3, 1%) and hyperpigmentation (overall, 8.1%; G3, 2.5%). At a 17-month follow-up, 28 (9.3%) patients experienced local recurrence/progression. Despite no convincing evidence that ECT confers improved outcomes compared with standard surgical excision, it can still be considered an opportunity to avoid major resection in patients unsuitable for more demanding treatment. Treatment naïvety and coverage of the deep margin predict tumour clearance and may inform current patient selection and management. |
format | Online Article Text |
id | pubmed-9406883 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-94068832022-08-26 Treatment of Basal Cell Carcinoma with Electrochemotherapy: Insights from the InspECT Registry (2008–2019) Bertino, Giulia Muir, Tobian Odili, Joy Groselj, Ales Marconato, Roberto Curatolo, Pietro Kis, Erika Lonkvist, Camilla Kjaer Clover, James Quaglino, Pietro Kunte, Christian Spina, Romina Seccia, Veronica de Terlizzi, Francesca Campana, Luca Giovanni Curr Oncol Article This prospective registry-based study aims to describe electrochemotherapy (ECT) modalities in basal cell carcinoma (BCC) patients and evaluate its efficacy, safety, and predictive factors. The International Network for Sharing Practices of Electrochemotherapy (InspECT) multicentre database was queried for BCC cases treated with bleomycin-ECT between 2008 and 2019 (n = 330 patients from seven countries, with 623 BCCs [median number: 1/patient; range: 1–7; size: 13 mm, range: 5–350; 85% were primary, and 80% located in the head and neck]). The procedure was carried out under local anaesthesia in 68% of cases, with the adjunct of mild sedation in the remaining 32%. Of 300 evaluable patients, 242 (81%) achieved a complete response (CR) after a single ECT course. Treatment naïvety (odds ratio [OR] 0.35, 95% confidence interval [C.I.] 0.19–0.67, p = 0.001) and coverage of deep tumour margin with electric pulses (O.R. 5.55, 95% C.I. 1.37–21.69, p = 0.016) predicted CR, whereas previous radiation was inversely correlated (O.R. 0.25, p = 0.0051). Toxicity included skin ulceration (overall, 16%; G3, 1%) and hyperpigmentation (overall, 8.1%; G3, 2.5%). At a 17-month follow-up, 28 (9.3%) patients experienced local recurrence/progression. Despite no convincing evidence that ECT confers improved outcomes compared with standard surgical excision, it can still be considered an opportunity to avoid major resection in patients unsuitable for more demanding treatment. Treatment naïvety and coverage of the deep margin predict tumour clearance and may inform current patient selection and management. MDPI 2022-07-28 /pmc/articles/PMC9406883/ /pubmed/36005161 http://dx.doi.org/10.3390/curroncol29080423 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Bertino, Giulia Muir, Tobian Odili, Joy Groselj, Ales Marconato, Roberto Curatolo, Pietro Kis, Erika Lonkvist, Camilla Kjaer Clover, James Quaglino, Pietro Kunte, Christian Spina, Romina Seccia, Veronica de Terlizzi, Francesca Campana, Luca Giovanni Treatment of Basal Cell Carcinoma with Electrochemotherapy: Insights from the InspECT Registry (2008–2019) |
title | Treatment of Basal Cell Carcinoma with Electrochemotherapy: Insights from the InspECT Registry (2008–2019) |
title_full | Treatment of Basal Cell Carcinoma with Electrochemotherapy: Insights from the InspECT Registry (2008–2019) |
title_fullStr | Treatment of Basal Cell Carcinoma with Electrochemotherapy: Insights from the InspECT Registry (2008–2019) |
title_full_unstemmed | Treatment of Basal Cell Carcinoma with Electrochemotherapy: Insights from the InspECT Registry (2008–2019) |
title_short | Treatment of Basal Cell Carcinoma with Electrochemotherapy: Insights from the InspECT Registry (2008–2019) |
title_sort | treatment of basal cell carcinoma with electrochemotherapy: insights from the inspect registry (2008–2019) |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406883/ https://www.ncbi.nlm.nih.gov/pubmed/36005161 http://dx.doi.org/10.3390/curroncol29080423 |
work_keys_str_mv | AT bertinogiulia treatmentofbasalcellcarcinomawithelectrochemotherapyinsightsfromtheinspectregistry20082019 AT muirtobian treatmentofbasalcellcarcinomawithelectrochemotherapyinsightsfromtheinspectregistry20082019 AT odilijoy treatmentofbasalcellcarcinomawithelectrochemotherapyinsightsfromtheinspectregistry20082019 AT groseljales treatmentofbasalcellcarcinomawithelectrochemotherapyinsightsfromtheinspectregistry20082019 AT marconatoroberto treatmentofbasalcellcarcinomawithelectrochemotherapyinsightsfromtheinspectregistry20082019 AT curatolopietro treatmentofbasalcellcarcinomawithelectrochemotherapyinsightsfromtheinspectregistry20082019 AT kiserika treatmentofbasalcellcarcinomawithelectrochemotherapyinsightsfromtheinspectregistry20082019 AT lonkvistcamillakjaer treatmentofbasalcellcarcinomawithelectrochemotherapyinsightsfromtheinspectregistry20082019 AT cloverjames treatmentofbasalcellcarcinomawithelectrochemotherapyinsightsfromtheinspectregistry20082019 AT quaglinopietro treatmentofbasalcellcarcinomawithelectrochemotherapyinsightsfromtheinspectregistry20082019 AT kuntechristian treatmentofbasalcellcarcinomawithelectrochemotherapyinsightsfromtheinspectregistry20082019 AT spinaromina treatmentofbasalcellcarcinomawithelectrochemotherapyinsightsfromtheinspectregistry20082019 AT secciaveronica treatmentofbasalcellcarcinomawithelectrochemotherapyinsightsfromtheinspectregistry20082019 AT deterlizzifrancesca treatmentofbasalcellcarcinomawithelectrochemotherapyinsightsfromtheinspectregistry20082019 AT campanalucagiovanni treatmentofbasalcellcarcinomawithelectrochemotherapyinsightsfromtheinspectregistry20082019 AT treatmentofbasalcellcarcinomawithelectrochemotherapyinsightsfromtheinspectregistry20082019 |